Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postoperative intravenous Venofer versus control after total hip or knee arthroplasty
NL-OMON30673Phase 3Active, not recruiting
- Sponsor
- Atrium Medisch Centrum Parkstad
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of iron sucrose in iron deficiency anemia (IDA) (2 arms), sponsored by Atrium Medisch Centrum Parkstad. Primary endpoints: Change in perioperative parameters of iron metabolism and erythropoiesis and Ret-Y. Started Aug 2007; status: active, not recruiting.
02
Drugs
iron sucrose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NL-OMON30673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON30673.